Bank of America’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.1K | Sell |
12,173
-18,220
| -60% | -$42.1K | ﹤0.01% | 5971 |
|
|
2025
Q1 | $237K | Sell |
30,393
-56
| -0.2% | -$437 | ﹤0.01% | 5124 |
|
|
2024
Q4 | $142K | Buy |
30,449
+4,015
| +15% | +$18.8K | ﹤0.01% | 5387 |
|
|
2024
Q3 | $142K | Buy |
26,434
+14,668
| +125% | +$79.1K | ﹤0.01% | 5316 |
|
|
2024
Q2 | $104K | Buy |
11,766
+2,998
| +34% | +$26.4K | ﹤0.01% | 5414 |
|
|
2024
Q1 | $103K | Sell |
8,768
-5,343
| -38% | -$62.8K | ﹤0.01% | 5373 |
|
|
2023
Q4 | $159K | Buy |
14,111
+9,640
| +216% | +$109K | ﹤0.01% | 5284 |
|
|
2023
Q3 | $30.3K | Hold |
4,471
| – | – | ﹤0.01% | 5725 |
|
|
2023
Q2 | $40.6K | Sell |
4,471
-246
| -5% | -$2.23K | ﹤0.01% | 5661 |
|
|
2023
Q1 | $30.5K | Buy |
4,717
+2,846
| +152% | +$18.4K | ﹤0.01% | 5826 |
|
|
2022
Q4 | $11.9K | Buy |
1,871
+13
| +0.7% | +$82 | ﹤0.01% | 6070 |
|
|
2022
Q3 | $12K | Hold |
1,858
| – | – | ﹤0.01% | 6320 |
|
|
2022
Q2 | $16K | Sell |
1,858
-1,700
| -48% | -$14.6K | ﹤0.01% | 6428 |
|
|
2022
Q1 | $30K | Sell |
3,558
-211
| -6% | -$1.78K | ﹤0.01% | 6574 |
|
|
2021
Q4 | $38K | Buy |
3,769
+1,970
| +110% | +$19.9K | ﹤0.01% | 6459 |
|
|
2021
Q3 | $35K | Buy |
1,799
+99
| +6% | +$1.93K | ﹤0.01% | 6302 |
|
|
2021
Q2 | $30K | Hold |
1,700
| – | – | ﹤0.01% | 6202 |
|
|
2021
Q1 | $20K | Hold |
1,700
| – | – | ﹤0.01% | 6185 |
|
|
2020
Q4 | $29K | Sell |
1,700
-1,000
| -37% | -$17.1K | ﹤0.01% | 5728 |
|
|
2020
Q3 | $28K | Buy |
2,700
+987
| +58% | +$10.2K | ﹤0.01% | 5549 |
|
|
2020
Q2 | $9K | Buy |
1,713
+13
| +0.8% | +$68 | ﹤0.01% | 5860 |
|
|
2020
Q1 | $6K | Sell |
1,700
-3
| -0.2% | -$11 | ﹤0.01% | 5845 |
|
|
2019
Q4 | $10K | Buy |
1,703
+3
| +0.2% | +$18 | ﹤0.01% | 5800 |
|
|
2019
Q3 | $10K | Buy |
1,700
+898
| +112% | +$5.28K | ﹤0.01% | 5875 |
|
|
2019
Q2 | $8K | Buy |
+802
| New | +$8K | ﹤0.01% | 5969 |
|